Germany moves forward with cannabis research oversight

Germany advances cannabis research through federal oversight

Germany has taken a significant step in its cannabis legalization process by designating the Federal Office for Agriculture and Food (BLE) to oversee cannabis research. This decision marks a shift from the Federal Institute for Drugs and Medical Devices (BfArM), which previously managed such projects.

The role of BLE in cannabis research

With the implementation of the Consumer Cannabis Science Responsibility Regulation, the BLE will now manage research applications for non-medical cannabis and industrial hemp. The new responsibilities include evaluating applications, granting approvals, and monitoring approved research projects.

According to Germany’s government, the new framework opens doors for universities and private companies to participate in research. Applicants must meet strict criteria under the Consumer Cannabis Act and demonstrate relevant expertise. This research is expected to:

• Expand knowledge about regulated cannabis use
• Support efforts to combat the illicit market
• Promote responsible health prevention measures

A phased approach to legalization

Germany enacted its cannabis legalization law (CanG) on April 1, 2024, allowing adults to cultivate and possess cannabis for personal use. In July 2024, Germany introduced member-based cultivation associations as part of the first phase of the legalization process.

The newly announced research oversight by BLE aligns with the nation’s focus on evidence-based policy decisions. By studying regulated cannabis systems, Germany aims to inform future phases, including pilot programs for cannabis specialty stores.

Further steps for pilot programs

While BLE’s appointment is a critical milestone, additional regulatory steps are required to launch regional pilot trials effectively. These pilot programs will test controlled sales of cannabis through authorized channels, a component often referred to as the “second pillar” of Germany’s cannabis legalization framework.

To carry out cannabis-related scientific research, applicants must seek permits for various activities such as cultivation, production, import, export, and trade, specifically for scientific purposes. Germany’s government emphasizes that these efforts are separate from broader commercial legalization plans.

Personal perspective

Germany's structured approach to cannabis legalization is a model worth observing. By prioritizing research and evidence-based regulations, the country is ensuring a balanced rollout that considers public safety, market control, and economic benefits.

As a journalist, I find this phased legalization strategy both cautious and innovative. The appointment of the BLE signifies Germany's commitment to transparency and scientific rigor in shaping its cannabis policies. While challenges remain, this step forward could set a precedent for other nations exploring similar paths.